Clinical Trial Update: Trastuzumab and Pertuzumab or Bevacizumab With Combination Chemotherapy in Treating Patients With Stage II-III Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating trastuzumab and pertuzumab or bevacizumab with combination chemotherapy in stage II–III breast cancer has completed with results posted…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Stage Iiia Breast Cancer
• Stage Iiib Breast Cancer
• Stage Iiic Breast Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)
• Pertuzumab (pertuzumab)
• Trastuzumab (trastuzumab)

Snippet

Sponsor: Case Comprehensive Cancer Center | Conditions: Stage II Breast Cancer, Stage IIIA Breast Cancer | Phase 2 | Status: COMPLETED | Results posted: 2019-03-05